Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P53 expression in breast cancer.

G Cattoretti1, F Rilke, S Andreola

  • 1Division of Anatomic Pathology and Cytology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

International Journal of Cancer
|February 15, 1988
PubMed
Summary

p53 protein in breast cancer is linked to aggressive tumor traits, including estrogen receptor-negative status and higher grade. This finding offers a new way to assess breast cancer biology and patient prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The effect of intensified training therapy on axial spondylarthritis in day care units].

Zeitschrift fur Rheumatologie·2023
Same author

miR-194-5p/BCLAF1 deregulation in AML tumorigenesis.

Leukemia·2017
Same author

miR-194-5p/BCLAF1 deregulation in AML tumorigenesis.

Leukemia·2017
Same author

A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Bimodal regulation of p21(waf1) protein as function of DNA damage levels.

Cell cycle (Georgetown, Tex.)·2014
Same author

Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10.

British journal of cancer·2014

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunohistochemistry

Background:

  • The p53 tumor suppressor gene plays a critical role in cellular response to DNA damage.
  • Alterations in p53 are common in various cancers, including breast cancer.
  • Understanding the specific associations of p53 expression in breast tumors is crucial for prognosis.

Purpose of the Study:

  • To investigate the correlation between p53 protein expression and various clinicopathological features in primary breast cancers.
  • To determine if p53 positivity is associated with specific tumor subtypes, receptor status, and proliferation markers.
  • To evaluate p53 as a potential biomarker for breast cancer cellular biology and prognosis.

Main Methods:

  • Immunohistochemical analysis of 200 primary breast cancers using anti-p53 monoclonal antibodies (MAbs) PAb421 and PAb1801.

Related Experiment Videos

  • Evaluation of p53 positivity in relation to estrogen receptor (ER), progesterone receptor (PR), epidermal growth factor receptor (EGF-R), Ki-67, human leukocyte antigen (HLA) class I antigens, and tumor grade.
  • Statistical analysis to determine significant associations between p53 status and clinicopathological parameters.

    • Main Results:

    • p53 positivity was observed in 15.5% of cases using PAb421 and 45.5% using PAb1801.
    • p53-positive tumors were significantly associated with EGF-R positivity, ER-negativity, and high Ki-67 scores.
    • p53-positive tumors also showed a higher incidence of grade-3 infiltrating duct carcinomas and low progesterone receptor values.

    Conclusions:

    • p53 protein expression in breast cancer is strongly associated with aggressive features such as ER-negativity, EGF-R positivity, and high proliferation.
    • These findings suggest that p53 is a valuable marker for understanding the cellular biology and predicting the prognosis of breast cancer.
    • Further research into p53's role could lead to improved therapeutic strategies for breast cancer patients.